🔍

TIRUMALCHM - Thirumalai Chem.

📊 NSE: TIRUMALCHM 🏢 Chemicals 📅 Last Updated: 12/14/2025 14:22

📢 Recent Corporate Announcements

Thirumalai Chemicals Appoints K. Anand Kumar as President-Finance; Independent Director Resigns

🟡 NEUTRAL ⭐ 6/10

MANAGEMENT 📅 14 Feb 2026, 05:38 PM

Thirumalai Chemicals Limited has appointed Mr. K. Anand Kumar as President-Finance and Senior Management Personnel, effective February 14, 2026. Simultaneously, Independent Director Mr. Arun Alagappan has resigned effective March 31, 2026, citing increased professional commitments at his own organization. The board also approved the unaudited financial results for the quarter ended December 31, 2025. Auditor reports indicate that one subsidiary contributed a revenue of ₹749 lakhs with a net loss of ₹347 lakhs for the quarter.

Appointment of Mr. K. Anand Kumar as President-Finance effective February 14, 2026.
Resignation of Independent Director Mr. Arun Alagappan effective March 31, 2026.
Approval of standalone and consolidated financial results for the quarter and nine months ended December 31, 2025.
One subsidiary reported a net loss of ₹347 lakhs on revenue of ₹749 lakhs for the December quarter.
The company maintains a network of 7 subsidiaries across Malaysia, Singapore, USA, Netherlands, and India.

💡 Investors should monitor the transition in the finance leadership for any shifts in fiscal strategy. The management changes appear routine and the independent director's resignation is not linked to any material governance issues.

Thirumalai Chemicals Q3 PAT Rises 44% YoY to ₹10.52 Cr; New Finance Head Appointed

🟢 POSITIVE ⭐ 7/10

EARNINGS 📅 14 Feb 2026, 04:41 PM

Thirumalai Chemicals reported a strong performance for the quarter ended December 31, 2025, with consolidated net profit rising 44% year-on-year to ₹10.52 crore. Consolidated revenue from operations grew by 9.2% to ₹504.82 crore compared to the same period last year. The company also announced the appointment of K. Anand Kumar as President-Finance to strengthen its senior management. While Independent Director Arun Alagappan resigned due to other professional commitments, the financial trajectory remains positive with sequential growth in both revenue and margins.

Consolidated Revenue from operations increased to ₹504.82 crore in Q3 FY26 from ₹462.15 crore in Q3 FY25.
Consolidated Net Profit (PAT) grew 44.1% YoY to ₹10.52 crore from ₹7.30 crore.
Standalone PAT stood at ₹9.28 crore, reflecting a 45.4% growth compared to ₹6.38 crore in the previous year's quarter.
Appointed K. Anand Kumar as President-Finance and Senior Management Personnel effective February 14, 2026.
Independent Director Arun Alagappan resigned effective March 31, 2026, citing professional commitments elsewhere.

💡 The company is demonstrating a healthy recovery in profitability and steady revenue growth. Investors should maintain a positive outlook while monitoring the impact of new leadership on financial strategy and operational efficiency.

ICRA Downgrades Thirumalai Chemicals to [ICRA]BBB+ (Negative) Over US Project Cost Overruns

🔴 NEGATIVE ⭐ 7/10

OTHER 📅 13 Jan 2026, 06:06 PM

ICRA has downgraded the credit ratings for Thirumalai Chemicals Limited's bank facilities and NCDs totaling over Rs. 1,317 crore. The long-term rating has been moved to [ICRA]BBB+ with a Negative outlook, while short-term ratings are now [ICRA]A2. The downgrade is primarily driven by a moderation in the company's operational performance and significant cost increases in its US-based project. This rating action reflects heightened credit risk and potential pressure on the company's balance sheet.

Long-term ratings for Rs. 437.05 crore term loans and Rs. 480.50 crore working capital downgraded to [ICRA]BBB+ (Negative).
Non-convertible debentures (NCDs) worth Rs. 100 crore downgraded to [ICRA]BBB+ (Negative).
Short-term ratings for non-fund based facilities totaling Rs. 100 crore downgraded to [ICRA]A2.
Downgrade attributed to moderated company performance and increased capital expenditure for the US project.
Total bank limits under surveillance amount to Rs. 1,217.55 crore plus Rs. 100 crore in NCDs.

💡 Investors should exercise caution as the downgrade and negative outlook signal rising financial stress due to US project delays or cost overruns. Monitor upcoming quarterly results for signs of margin stabilization and updates on the US project's funding requirements.

Thirumalai Chemicals Submits SEBI Reg 74(5) Compliance Certificate for Q3 FY26

🟡 NEUTRAL ⭐ 2/10

ROUTINE 📅 10 Jan 2026, 10:13 PM

Thirumalai Chemicals has filed its quarterly compliance certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations for the quarter ended December 31, 2025. The certificate, issued by the Registrar & Transfer Agent MUFG Intime India Private Limited, confirms that all dematerialization requests were processed within the mandated timelines. It verifies that physical security certificates were mutilated and cancelled after due verification and the name of the depositories substituted in the register of members. This filing is a standard procedural requirement to ensure the integrity of the company's shareholding data.

Compliance certificate submitted for the quarter ended December 31, 2025.
Issued by Registrar & Transfer Agent MUFG Intime India Private Limited (formerly Link Intime).
Confirms that securities received for dematerialization were processed and listed on stock exchanges.
Verification and cancellation of physical certificates completed within prescribed SEBI timelines.

💡 No action is required as this is a routine regulatory filing. Investors should continue to monitor the company's operational performance and upcoming quarterly financial results.

Thirumalai Chemicals Starts US Operations; 40,500 TPA Maleic Anhydride Plant Begins Sales

🟢 POSITIVE ⭐ 8/10

EXPANSION 📅 02 Jan 2026, 09:47 PM

Thirumalai Chemicals' US subsidiary, TCL Specialties LLC, has commenced the first phase of commercial operations at its new manufacturing facility with the first sale of Maleic Anhydride (MAN). The facility features a MAN plant with a capacity of 40,500 tons per year and a food ingredients plant with over 30,000 tons per year capacity for Malic and Fumaric acid. The company expects the phased commissioning process to be fully stabilized during the first half of calendar year 2026. This expansion targets underserved markets in the North-Eastern and Mid-West US, providing a significant footprint in the North American specialty chemicals sector.

Commencement of first phase commercial operations with the first sale of Maleic Anhydride (MAN)
Maleic Anhydride (MAN) plant capacity of approximately 40,500 tons per year (~90 million lbs/yr)
Food ingredients plant capacity of over 30,000 tons per year for Malic acid and Fumaric acid
Phased commissioning and stabilization expected to be completed during H1 of calendar year 2026
Strategic entry into underserved North-Eastern and Mid-West US regional markets

💡 Investors should monitor the ramp-up of the US facility as it represents a major capacity addition and geographic diversification. The successful stabilization by H1 2026 could significantly boost the company's top-line and global market share in specialty chemicals.

Thirumalai Chemicals to Close Trading Window from Jan 1, 2026 for Q3 Results

🟡 NEUTRAL ⭐ 2/10

ROUTINE 📅 29 Dec 2025, 06:43 PM

Thirumalai Chemicals Limited has announced the closure of its trading window for all designated persons and their immediate relatives starting January 1, 2026. This move is a standard regulatory requirement under SEBI (Prohibition of Insider Trading) Regulations, 2015. The closure is in anticipation of the un-audited financial results for the quarter ending December 31, 2025. The trading window will reopen 48 hours after the financial results are officially declared to the stock exchanges.

Trading window closure effective from Thursday, January 1, 2026.
Closure pertains to the un-audited financial results for the quarter ended December 31, 2025.
The window will remain closed until 48 hours after the results are announced.
Compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015.

💡 No action is required as this is a routine regulatory filing. Investors should look out for the upcoming quarterly results announcement for fundamental performance updates.

Thirumalai Chemicals Allots 18.96 Lakh Shares to Promoters, Raising ₹56.14 Crores

🟢 POSITIVE ⭐ 7/10

FUNDRAISE 📅 23 Dec 2025, 04:00 PM

Thirumalai Chemicals has successfully completed the allotment of 1,896,614 equity shares on a preferential basis to its promoter group at a price of ₹296 per share. This transaction has raised approximately ₹56.14 crores for the company, with the promoter group entity Ultramarine and Pigments Ltd contributing the bulk of the investment (₹45 crores). The allotment increases the company's total paid-up capital from 11.87 crore shares to 12.06 crore shares. This capital infusion by the promoters signals strong internal confidence in the company's long-term growth prospects.

Allotment of 1,896,614 equity shares of face value ₹1 each at an issue price of ₹296 per share.
Total fundraise aggregates to ₹56,13,97,744 through a preferential issue to 16 promoter group entities.
Ultramarine and Pigments Ltd emerged as the largest allottee, subscribing to 1,520,270 shares.
Post-allotment, the company's paid-up capital has increased to ₹12,05,52,774 divided into 12.05 crore shares.

💡 Investors should take note of the promoter group's decision to infuse capital at ₹296 per share, which serves as a benchmark for valuation and a sign of management's commitment. Monitor the company's upcoming quarterly results to see how this additional capital is deployed for operational expansion.

TIRUMALCHM: Malaysia Unit Outage Prolonged; ₹235 Cr Revenue Impact

🔴 NEGATIVE ⭐ 7/10

REGULATORY 📅 05 Dec 2025, 10:58 PM

Thirumalai Chemicals' step-down subsidiary, Optimistic Organic Sdn Bhd (OOSB) in Malaysia, faces a prolonged outage of its Maleic Anhydride unit due to machinery failure. This is expected to reduce consolidated revenue by ₹235 Cr annually, representing 9.6% of FY25 consolidated revenue. The outage has already resulted in an approximate revenue reduction of ₹118 crore in H1 FY26. The Maleic Anhydride unit constituted about 4% (₹140 crore) of the consolidated net worth as at the end of FY25. The derivatives plant of OOSB continues to operate.

Maleic Anhydride unit outage expected to reduce consolidated revenue by ₹235 Cr annually.
Maleic Anhydride business contributed about 9.6% of FY25 consolidated revenue.
Outage resulted in approximately ₹118 crore reduction in revenue in H1 FY26.
Maleic Anhydride unit constituted about ₹140 crore of the consolidated net worth as at end of FY25.

💡 Investors should closely monitor the progress of the repairs and the impact on Thirumalai Chemicals' consolidated financials. Consider the reduced revenue guidance when evaluating the company's future performance.

View All TIRUMALCHM Announcements on Live Market Tracking →

💰 Financial Performance

Revenue Growth by Segment

Standalone revenue grew 8.3% YoY to INR 2,152.07 Cr in FY25, while consolidated revenue declined 1.6% to INR 2,049.51 Cr. The US subsidiary (TCL Global BV) saw a 20% revenue decline to USD 27.82 Mn in FY25 due to market instability.

Geographic Revenue Split

India operations contributed INR 2,152.07 Cr (Standalone) in FY25. The United States subsidiary contributed USD 27.82 Mn (approx. INR 230 Cr), representing roughly 11% of consolidated revenue. The company is focusing its full attention on these two primary markets.

Profitability Margins

Standalone PAT margin improved from 1.8% to 3.8% in FY25, with PAT rising 126% to INR 82.21 Cr. However, consolidated PAT was a loss of INR 46.10 Cr in FY25, worsening from a loss of INR 38.79 Cr in FY24 due to subsidiary underperformance.

EBITDA Margin

Standalone EBITDA margin improved from 6.2% to 8.4% in FY25, with EBITDA rising 45% to INR 182.89 Cr. Consolidated EBITDA margin remained flat at 3.4% (INR 69.40 Cr). Q1 FY26 standalone EBITDA margin crashed to 1.5% from 10.1% YoY due to reduced PAN-OX spreads.

Capital Expenditure

Consolidated Property, Plant and Equipment (PPE) increased 93% to INR 1,145 Cr in FY25, with Capital Work-in-Progress (CWIP) at INR 1,352 Cr. The company is investing INR 330 Cr for US capital expenditure and additional funds for manufacturing projects in Dahej, Gujarat.

Credit Rating & Borrowing

ICRA maintains a 'Negative' outlook due to margin pressure. Consolidated non-current borrowings surged 72% to INR 1,401 Cr in FY25. The company faces principal repayment obligations of INR 81 Cr in H2 FY2026 and INR 133 Cr in FY2027.

⚙️ Operational Drivers

Raw Materials

Orthoxylene (OX) is the primary raw material for Phthalic Anhydride (PAN) production. Standalone cost of materials consumed was INR 1,381 Cr in FY25, representing 64.2% of standalone revenue.

Import Sources

Producers from the Far East and China are noted as major competitors and sources of dumping, impacting the Indian market for commodities and food ingredients.

Capacity Expansion

Expanding manufacturing projects through subsidiaries in Dahej, Gujarat and the United States (TCL Specialties LLC). PPE and CWIP combined total INR 2,497 Cr as of March 2025, indicating massive capacity buildup.

Raw Material Costs

Standalone raw material costs decreased 4.8% YoY to INR 1,381 Cr in FY25 despite higher revenue, reflecting better procurement. However, margins remain highly susceptible to the volatility in PAN-OX spreads.

Manufacturing Efficiency

The company is driving process improvements and drawing on 15 years of leadership experience to manage expansion. Capacity expansions are expected to be absorbed over the next 12 to 15 months.

📈 Strategic Growth

Growth Strategy

Strategy involves capacity expansion in Dahej and the US, divestment of non-core or struggling subsidiary parts to focus on India/US markets, and absorption of new capacity over 12-15 months to improve margins.

Products & Services

Phthalic Anhydride (PA), Maleic Anhydride (MAN), Speciality Chemicals, and Food Ingredients.

Brand Portfolio

Thirumalai Chemicals Limited (TCL).

New Products/Services

Focusing on Speciality Chemicals and Food Ingredients, which serve robustly growing markets, though currently facing margin pressure from Far East competition.

Market Expansion

Targeting India and the United States for long-term growth. Capital infusion of INR 327.53 Cr was made into the Netherlands subsidiary for onward investment into the US project.

🌍 External Factors

Industry Trends

The industry is currently in a 'bad patch' regarding margins due to Far East oversupply, but volume demand remains robust. Recovery is expected as Far East markets stabilize and domestic capacity is absorbed.

Competitive Landscape

Intense competition from Far East commodity chemical producers who dump products into India using regulatory gaps.

Competitive Moat

Moat is built on a 50-year track record, cost-leadership through process optimization, and robust safety/environmental management (Zero-Liquid Discharge). Sustainability depends on maintaining manufacturing controls.

Macro Economic Sensitivity

Highly sensitive to global oil price volatility and economic slowdowns in China and the Far East, which lead to dumping in the Indian market.

Consumer Behavior

Robust growth in end-user industries for PA and food ingredients supports volume insulation despite margin volatility.

Geopolitical Risks

Trade barriers and regulatory gaps in India are being plugged by the government to prevent toxic/substandard dumping from Far East producers.

⚖️ Regulatory & Governance

Industry Regulations

Subject to pollution norms and manufacturing standards. The company led campaigns for the GOI to plug regulatory gaps ensuring substandard/toxic products are not dumped in India.

Environmental Compliance

Maintains zero-liquid discharge and invested in latest water treatment technology. CSR average net profit is INR 139.01 Cr, with a 2% obligation of INR 2.78 Cr.

Taxation Policy Impact

Standalone effective tax rate was approximately 21% in FY25 (INR 22 Cr tax on INR 105 Cr PBT).

Legal Contingencies

The company has filed an appeal with the Securities Appellate Tribunal (SAT) in Mumbai against fines imposed by Stock Exchanges regarding the reconstitution of Board committees (NRC, SRC, RMC).

⚠️ Risk Analysis

Key Uncertainties

Volatility in PAN-OX spreads and the successful absorption of massive new capacity in the US and Dahej are primary risks, with potential margin impact exceeding 5-10%.